Vancomycin in ICU Patients with Gram-Positive Infections: Initial Trough Levels and Mortality

BACKGROUND: Vancomycin is one of the most common therapeutic agents for treating gram-positive infections, particularly in critically ill patients. The aim of this study was to identify factors associated with initial therapeutic vancomycin trough levels and mortality in a tertiary-care intensive ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshehri, Nadiyah, Ahmed, Anwar E, Yenugadhati, Nagarajkumar, Javad, Sundas, Al Sulaiman, Khalid, M Al-Dorzi, Hasan, Aljerasiy, Majed, Badri, Motasim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569025/
https://www.ncbi.nlm.nih.gov/pubmed/33116547
http://dx.doi.org/10.2147/TCRM.S266295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569025/
https://www.ncbi.nlm.nih.gov/pubmed/33116547
http://dx.doi.org/10.2147/TCRM.S266295

Ejemplares similares